These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 1373549

  • 1. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
    Neurath AR, Strick N, Jiang S.
    Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
    [Abstract] [Full Text] [Related]

  • 2. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR, Strick N, Lee ES.
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM, Ding L, Gabriel J.
    AIDS; 1998 Jan 22; 12(2):147-56. PubMed ID: 9468363
    [Abstract] [Full Text] [Related]

  • 4. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH, Peña LP, Tanty CR, Higginson Clarke D, Arenas MA, Noguerol KR, León CS.
    Prep Biochem Biotechnol; 2004 Aug 22; 34(3):227-37. PubMed ID: 15461139
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.
    McKenna PM, Pomerantz RJ, Dietzschold B, McGettigan JP, Schnell MJ.
    J Virol; 2003 Dec 22; 77(23):12782-94. PubMed ID: 14610200
    [Abstract] [Full Text] [Related]

  • 8. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ, McKenna PM, Arnold BA, Keller PM, Gorny MK, Zolla-Pazner S, Robinson JE, Conley AJ.
    AIDS Res Hum Retroviruses; 1997 Dec 10; 13(18):1549-59. PubMed ID: 9430247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
    Burkly L, Mulrey N, Blumenthal R, Dimitrov DS.
    J Virol; 1995 Jul 10; 69(7):4267-73. PubMed ID: 7769687
    [Abstract] [Full Text] [Related]

  • 11. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).
    Neurath AR, Strick N.
    Mol Immunol; 1990 Jun 10; 27(6):539-49. PubMed ID: 1696353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF, Arthur LO, Frost P, Matthews TJ, Langlois AJ, Palker TJ, Hart MK, Scearce RM, Jones DM, McDanal C.
    J Exp Med; 1993 Mar 01; 177(3):717-27. PubMed ID: 7679708
    [Abstract] [Full Text] [Related]

  • 14. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM, Berg W, Lewis GK, DeVico AL.
    J Virol; 2002 Dec 01; 76(23):12123-34. PubMed ID: 12414953
    [Abstract] [Full Text] [Related]

  • 15. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
    Neurath AR, Strick N, Lin K, Jiang S.
    AIDS Res Hum Retroviruses; 1995 Jun 01; 11(6):687-96. PubMed ID: 7576928
    [Abstract] [Full Text] [Related]

  • 16. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
    Park EJ, Gorny MK, Zolla-Pazner S, Quinnan GV.
    J Virol; 2000 May 01; 74(9):4183-91. PubMed ID: 10756031
    [Abstract] [Full Text] [Related]

  • 17. gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment.
    Marcon L, Sodroski J.
    J Virol; 1994 Mar 01; 68(3):1977-82. PubMed ID: 8107258
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Koot M, Kuiken CL, Goudsmit J.
    Virology; 1994 Jun 01; 201(2):285-93. PubMed ID: 7514319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.